Antiviral nanoagents: More attention and effort needed?
Nano Today
; 35: 100976, 2020 Dec.
Article
in English
| MEDLINE | ID: covidwho-779474
ABSTRACT
The recent COVID-19 outbreak has increasingly engaged researchers in the search for effective antiviral drugs as well as therapeutic treatment options. The shortcomings of existing antiviral agents such as narrow spectrum and low bioavailability, can be overcome through the use of engineered nanomaterials, which, therefore, are considered as a significant next-generation therapeutic option. Thus, the development of novel antiviral nanoagents will certainly help address several future challenges and knowledge gaps.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Language:
English
Journal:
Nano Today
Year:
2020
Document Type:
Article
Affiliation country:
J.nantod.2020.100976
Similar
MEDLINE
...
LILACS
LIS